Short-distance walking speed and timed walking distance: Redundant measures for clinical trials?
Short-distance walking speed and timed walking distance: Redundant measures for clinical trials?
复制标题
DOI：
10.1212/01.wnl.0000198502.88147.dd
复制
发表时间：
2006-02-28
期刊：
影响因子：
9.9
通讯作者：
Dobkin, BH
中科院分区：
文献类型：
--
作者：
Dobkin, BH
在脑卒中康复的临床试验中，15米步行速度和步行耐力（6分钟走完的距离）被认为是不同的结果。然而，在24名慢性偏瘫患者中，每个任务使用的舒适速度没有显著差异。虽然速度和耐力在通常速度为0.5 m/s的门诊患者中没有反映出不同的疗效领域，但最快可行的15米速度增强了这些指标。
The velocity of a 15-meter walk and walking endurance ( distance covered in 6 minutes) are considered distinct outcomes in clinical trials of stroke rehabilitation. Comfortable velocities used for each task in 24 subjects with chronic hemiparesis were not significantly different, however. Although speed and endurance did not reflect different domains of efficacy in outpatients whose usual speed was > 0.5 m/s, the fastest feasible 15-meter velocity augmented these measures.